Literature DB >> 6146324

Acute haemodynamic effects of oral prenalterol in severe heart failure.

M C Petch, C Wisbey, O Ormerod, C Scott, R M Goodfellow.   

Abstract

The acute haemodynamic effects of oral prenalterol were studied in 14 patients with severe heart failure (NYHA class III) due to ischaemic heart disease. All had received treatment with digoxin, diuretics, and in most cases vasodilators. Prenalterol was administered at two hourly intervals to give cumulative doses of 20, 50, and 100 mg and mean plasma concentrations of 53, 97, and 175 nmol/l. Haemodynamic measurements were made two hours after each dose with Swan-Ganz catheterisation; cardiac output was measured by thermodilution. There were no significant changes in heart rate, mean arterial pressure, or pulmonary artery diastolic pressure after the drug. Cardiac index rose significantly after 50 mg and 100 mg prenalterol. Oral prenalterol has a beneficial short term haemodynamic effect in patients with severe heart failure. If this effect is sustained prenalterol may be of value in the long term management of patients with this disabling condition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146324      PMCID: PMC481583          DOI: 10.1136/hrt.52.1.49

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  15 in total

1.  Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists.

Authors:  E Carlsson; C G Dahlöf; A Hedberg; H Persson; B Tångstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

2.  Digoxin for heart failure in sinus rhythm.

Authors:  M C Petch
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

3.  Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.

Authors:  A C Tweddel; R G Murray; D Pearson; W Martin; I Hutton
Journal:  Br Heart J       Date:  1982-04

4.  Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.

Authors:  W S Colucci; R W Alexander; G H Williams; R E Rude; B L Holman; M A Konstam; J Wynne; G H Mudge; E Braunwald
Journal:  N Engl J Med       Date:  1981-07-23       Impact factor: 91.245

5.  Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.

Authors:  N A Awan; K E Needham; M K Evenson; A Win; D T Mason
Journal:  Am Heart J       Date:  1981-02       Impact factor: 4.749

6.  Hemodynamic effects of intravenous prenalterol in severe heart failure.

Authors:  P C Kirlin; B Pitt
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

7.  Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.

Authors:  W T Manders; S F Vatner; E Braunwald
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

8.  Evaluation of digitalis in cardiac failure.

Authors:  R G Murray; A C Tweddel; W Martin; D Pearson; I Hutton; T D Lawrie
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-22

9.  Heart failure in outpatients: a randomized trial of digoxin versus placebo.

Authors:  D C Lee; R A Johnson; J B Bingham; M Leahy; R E Dinsmore; A H Goroll; J B Newell; H W Strauss; E Haber
Journal:  N Engl J Med       Date:  1982-03-25       Impact factor: 91.245

10.  Long-term digitalis therapy improves left ventricular function in heart failure.

Authors:  S B Arnold; R C Byrd; W Meister; K Melmon; M D Cheitlin; J D Bristow; W W Parmley; K Chatterjee
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

View more
  2 in total

Review 1.  Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.

Authors:  David Ho; Lin Yan; Kousaku Iwatsubo; Dorothy E Vatner; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

2.  Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

Authors:  D R Glover; C G Wathen; R G Murray; M C Petch; A L Muir; W A Littler
Journal:  Br Heart J       Date:  1985-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.